Review ArticleClinical Review

Addressing Needs of Transgender Patients: The Role of Family Physicians

Asa E. Radix
The Journal of the American Board of Family Medicine March 2020, 33 (2) 314-321; DOI: https://doi.org/10.3122/jabfm.2020.02.180228

References

  1. 1.↵
    1. Meerwijk EL,
    2. Sevelius JM
    . Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health 2017;107:216.
    OpenUrl
  2. 2.↵
    1. Hembree WC,
    2. Cohen-Kettenis P,
    3. Delemarre-van de Waal HA,
    4. et al
    . Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009;94:3132–3154.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    American Academy of Family Physicians. Recommended curriculum guidelines for family medicine residents lesbian, gay, bisexual, transgender health. In: AAFP, ed. AAFP Reprint No. 289D. August 2016.
  4. 4.↵
    American Academy of Family Physicians. American Academy of Family Physicians, AAFP policy statements: discrimination, patient (1996, 2010 COD). 2010.
  5. 5.↵
    1. Coutin A,
    2. Wright S,
    3. Li C,
    4. Fung R
    . Missed opportunities: are residents prepared to care for transgender patients? A study of family medicine, psychiatry, endocrinology, and urology residents. Can Med Ed J 2018;9:e41–e55.
    OpenUrl
  6. 6.↵
    1. Schwend AS,
    2. Motmans J,
    3. Smiley A,
    4. et al.
    Language and trans health AU—Bouman, Walter Pierre. Int J Transgenderism 2017;18:1–6.
    OpenUrl
  7. 7.↵
    1. James SE,
    2. Herman JL,
    3. Rankin S,
    4. Keisling M,
    5. Mottet L,
    6. Anafi M
    . The report of the 2015 U.S. Transgender Survey, Washington, DC: National Center for Transgender Equality; 2016.
  8. 8.↵
    1. Liszewski W,
    2. Peebles JK,
    3. Yeung H,
    4. Arron S
    . Persons of nonbinary gender—Awareness, visibility, and health disparities. N Engl J Med 2018;379:2391–2393.
    OpenUrl
  9. 9.↵
    1. Reisner SL,
    2. Radix A,
    3. Deutsch MB
    . Integrated and gender-affirming transgender clinical care and research. JAIDS 2016;72:S235–242.
    OpenUrl
  10. 10.↵
    1. Cahill S,
    2. Singal R,
    3. Grasso C,
    4. et al
    . Do ask, do tell: high levels of acceptability by patients of routine collection of sexual orientation and gender identity data in four diverse American community health centers. PLoS ONE 2014;9:e107104.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Commission TJ
    Advancing effective communication, cultural competence, and patient- and family-centered care for the lesbian, gay, bisexual, and transgender (lgbt) community: a field guide. In: Commission TJ, ed. Oak Brook, IL: The Joint Commision; 2011.
  12. 12.↵
    Institute of Medicine; Board on the Health of Select Populations; Committee on Lesbian, Gay, Bisexual, and Transgender Health Issues and Research Gaps and Opportunities. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. Washington, DC: National Academies Press; 2011.
  13. 13.↵
    1. Rullo JE,
    2. Foxen JL,
    3. Griffin JM,
    4. et al
    . Patient acceptance of sexual orientation and gender identity questions on intake forms in outpatient clinics: a pragmatic randomized multisite trial. Health Serv Res 2018;53:3790–3808.
    OpenUrl
  14. 14.↵
    1. Haider A,
    2. Adler RR,
    3. Schneider E,
    4. et al
    . Assessment of patient-centered approaches to collect sexual orientation and gender identity information in the emergency department: the EQUALITY study. JAMA Netw Open 2018;1:e186506.
    OpenUrl
  15. 15.↵
    1. Deutsch M
    Center of Excellence for Transgender Health DoFaCM, University of California San Francisco. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. In: Deutsch M, ed. 2nd ed, San Francisco, CA; University of California San Francisco, 2016. Available from: www.transhealth.ucsf.edu/. Accessed December 20, 2018.
  16. 16.↵
    1. Croghan CF,
    2. Moone RP,
    3. Olson AM
    . Working with LGBT baby boomers and older adults: factors that signal a welcoming service environment. J Gerontologic Soc Work 2015;58:637–651.
    OpenUrl
  17. 17.↵
    1. Kano M,
    2. Silva-Banuelos AR,
    3. Sturm R,
    4. Willging CE
    . Stakeholders’ recommendations to improve patient-centered “LGBTQ” primary care in rural and multicultural practices. J Am Board Fam Med 2016;29:156–160.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Prevention CfDCa. Act Against AIDS. Available from: https://www.cdc.gov/actagainstaids/.
  19. 19.↵
    1. Willging CE,
    2. Salvador M,
    3. Kano M
    . Brief reports: unequal treatment: mental health care for sexual and gender minority groups in a rural state. Psych Serv 2006;57:867–870.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Coleman E,
    2. Bockting W,
    3. Botzer M,
    4. et al
    . Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgender 2012;13:165–232.
    OpenUrlCrossRef
  21. 21.↵
    Center of Excellence for Transgender Health. Primary care protocol for transgender patient care. 2011. Available from: http://transhealth.ucsf.edu/trans?page=protocol-00-00.
  22. 22.↵
    1. Tangpricha V,
    2. den Heijer M
    . Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol 2017;5:291–300.
    OpenUrl
  23. 23.↵
    1. Schechter LS
    . Gender confirmation surgery: an update for the primary care provider. Transgender Health 2016;1:32–40.
    OpenUrl
  24. 24.↵
    1. Hembree WC,
    2. Cohen-Kettenis PT,
    3. Gooren L,
    4. et al
    . Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab 2017;102:3869–3903.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Schechter LS,
    2. Safa B
    . Introduction to phalloplasty. Clinics Plastic Surg 2018;45:387–389.
    OpenUrl
  26. 26.↵
    1. de Vries AL,
    2. McGuire JK,
    3. Steensma TD,
    4. Wagenaar EC,
    5. Doreleijers TA,
    6. Cohen-Kettenis PT
    . Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics 2014;134:696–704.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. White Hughto JM,
    2. Reisner SL
    . A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals. Transgender Health 2016;1:21–31.
    OpenUrl
  28. 28.↵
    1. Getahun D,
    2. Nash R,
    3. Flanders WD,
    4. et al
    . Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med 2018;169:205–213.
    OpenUrl
  29. 29.↵
    1. Elbers JMH,
    2. Giltay EJ,
    3. Teerlink T,
    4. et al
    . Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol 2003;58:562–571.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Maraka S,
    2. Singh Ospina N,
    3. Rodriguez-Gutierrez R,
    4. et al
    . Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab 2017;102:3914–3923.
    OpenUrl
  31. 31.↵
    1. Mattawanon N,
    2. Spencer JB,
    3. Schirmer DA 3rd.,
    4. Tangpricha V
    . Fertility preservation options in transgender people: A review. Rev Endocr Metab Disord 2018;19:231–242.
    OpenUrl
  32. 32.↵
    1. Peitzmeier SM,
    2. Khullar K,
    3. Reisner SL,
    4. Potter J
    . Pap test use is lower among female-to-male patients than non-transgender women. Am J Prevent Med 2014;47:808–812.
    OpenUrl
  33. 33.↵
    1. Tabaac AR,
    2. Sutter ME,
    3. Wall CSJ,
    4. Baker KE
    . Gender identity disparities in cancer screening behaviors. Am J Prevent Med 2018;54:385–393.
    OpenUrl
  34. 34.↵
    1. Bradford J,
    2. Reisner SL,
    3. Honnold JA,
    4. Xavier J
    . Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health 2013;103:1820–1829.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Herbst JH,
    2. Jacobs ED,
    3. Finlayson TJ,
    4. et al
    . Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav 2008;12:1–17.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Peitzmeier SM,
    2. Reisner SL,
    3. Harigopal P,
    4. Potter J
    . Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening. J Gen Intern Med 2014;29:778–784.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Reisner SL,
    2. Deutsch MB,
    3. Peitzmeier SM,
    4. et al
    . Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS ONE 2018;13:e0190172.
    OpenUrl
  38. 38.↵
    1. Ganly I,
    2. Taylor EW
    . Breast cancer in a trans-sexual man receiving hormone replacement therapy. Br J Surg 1995;82:341–341.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Burcombe RJ,
    2. Makris A,
    3. Pittam M,
    4. Finer N
    . Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. The Breast 2003;12:290–293.
    OpenUrl
  40. 40.↵
    1. Nikolic DV,
    2. Djordjevic ML,
    3. Granic M,
    4. et al
    . Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Surg Onc 2012;10:280–280.
    OpenUrl
  41. 41.↵
    1. Deutsch MB,
    2. Radix A,
    3. Wesp L
    . Breast cancer screening, management, and a review of case study literature in transgender populations. Semin Reprod Med 2017;35:434–441.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Light AD,
    2. Obedin-Maliver J,
    3. Sevelius JM,
    4. Kerns JL
    . Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol 2014;124:1120–1127.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Light A,
    2. Wang LF,
    3. Zeymo A,
    4. Gomez-Lobo V
    . Family planning and contraception use in transgender men. Contraception 2018;98:266–269.
    OpenUrl
  44. 44.↵
    1. Baral SD,
    2. Poteat T,
    3. Stromdahl S,
    4. Wirtz AL,
    5. Guadamuz TE,
    6. Beyrer C
    . Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 2013;13:214–222.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Becasen JS,
    2. Denard CL,
    3. Mullins MM,
    4. Higa DH,
    5. Sipe TA
    . Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health 2018;e1–e8.
  46. 46.↵
    1. Reisner SL,
    2. Murchison GR
    . A global research synthesis of HIV and STI biobehavioural risks in female-to-male transgender adults. Global Pub Health 2016;11:866–887.
    OpenUrl
  47. 47.↵
    1. Mizuno Y,
    2. Frazier EL,
    3. Huang P,
    4. Skarbinski J
    . Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health 2015;2:228–234.
    OpenUrl
  48. 48.↵
    1. Doshi RK,
    2. Milberg J,
    3. Jumento T,
    4. Matthews T,
    5. Dempsey A,
    6. Cheever LW
    . For many served by the Ryan White HIV/AIDS program, disparities in viral suppression decreased, 2010–14. Health Aff (Project Hope) 2017;36:116–123.
    OpenUrl
  49. 49.↵
    1. Grant JM,
    2. Mottet LA,
    3. Tanis J
    . National transgender discrimination survey report on health and health care. Washington, DC: National Center for Transgender Equality and the National Gay and Lesbian Task Force; 2010.
  50. 50.↵
    1. Machtinger EL,
    2. Haberer JE,
    3. Wilson TC,
    4. Weiss DS
    . Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav 2012;16:2160–2170.
    OpenUrlPubMed
  51. 51.↵
    1. Sevelius JM,
    2. Patouhas E,
    3. Keatley JG,
    4. Johnson MO
    . Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med 2013;47:5–16.
    OpenUrl
  52. 52.↵
    1. Sevelius JM,
    2. Carrico A,
    3. Johnson MO
    . Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care 2010;21:256–264.
    OpenUrlCrossRefPubMedWeb of Science
  53. 53.↵
    1. Braun HM,
    2. Candelario J,
    3. Hanlon CL,
    4. et al
    . Transgender women living with HIV frequently take antiretroviral therapy and/or feminizing hormone therapy differently than prescribed due to drug-drug interaction concerns. LGBT Health 2017;4:371–375.
    OpenUrl
  54. 54.↵
    1. Potter J,
    2. Peitzmeier SM,
    3. Bernstein I,
    4. et al
    . Cervical cancer screening for patients on the female-to-male spectrum: a narrative review and guide for clinicians. J Gen Intern Med 2015;30:1857–1864.
    OpenUrl
  55. 55.↵
    1. Workowski KA,
    2. Bolan GA
    . Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64:1–137.
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. Moyer VA
    . Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2013;159:51–60.
    OpenUrlCrossRefPubMedWeb of Science
  57. 57.↵
    1. Branson BM,
    2. Handsfield HH,
    3. Lampe MA,
    4. et al
    . Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55:1–17. Quiz CE11–14.
    OpenUrlPubMed
  58. 58.↵
    1. Pitasi MA,
    2. Kerani RP,
    3. Kohn R,
    4. et al
    . Chlamydia, gonorrhea, and human immunodeficiency virus infection among transgender women and transgender men attending clinics that provide sexually transmitted disease services in six US cities: results from the Sexually Transmitted Disease Surveillance Network. Sex Transm Dis 2019;46:112–117.
    OpenUrl
  59. 59.↵
    Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1–infected adults and adolescents. Washington, DC: Department of Health and Human Services; 2018
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords